Quinolone derivatives and processes for the preparation thereof

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544 9, 544 32, 544 66, 544101, 546100, 546113, 546123, C07D21556, C07D47104

Patent

active

058178201

ABSTRACT:
The present invention relates to optical isomers of quinoline compounds of Formula (IA) or Formula (IA'), their pharmaceutically acceptable salts and their intermediates: ##STR1## In the above formulae, A represent nitrogen or ##STR2## in which Y represents hydrogen, halogen such as fluorine or chlorine, lower alkyl or lower alkoxy such as methoxy, or together with R.sub.1 forms --CH.sub.2 CH.sub.2 CH.sub.2 --, CH.sub.2 CH.sub.2 CH(CH.sub.3)--, --OCH.sub.2 CH.sub.2 --, --OCH.sub.2 CH(CH.sub.3)--, --SCH.sub.2 CH.sub.2 -- or --SCH.sub.2 CH(CH.sub.3)--; R.sub.1 is as defined above or represents straight chain or cyclic lower alkyl group having 1 to 3 carbon atoms, a straight chain or cyclic lower alkyl group having 1 to 3 carbon atoms which is substituted with a halogen atom, a phenyl group or a phenyl group substituted with one or two halogen atoms, such as ethyl, cyclopropyl or 2,4-difluorophenyl; R.sub.4 represents hydrogen, lower alkyl, lower alkoxy, or an amino-protecting group, such as methyl, ethyl or butoxycarbonyl; R.sub.5, R.sub.6, R.sub.7 and R.sub.8 may be the same or different and represent independently hydrogen, lower alkyl optionally substituted by amino, hydroxy or halogen, such as methyl or ethyl; and X represents hydrogen, halogen such as fluorine or chlorine, amino or lower alkyl such as methyl.

REFERENCES:
patent: 4146719 (1979-03-01), Irikura
patent: 4563459 (1986-01-01), Grohe et al.
patent: 4954507 (1990-09-01), Weber et al.
patent: 4965273 (1990-10-01), Weber et al.
patent: 4990517 (1991-02-01), Petersen et al.
patent: 5017581 (1991-05-01), Nishitani et al.
patent: 5059597 (1991-10-01), Petersen et al.
patent: 5091384 (1992-02-01), Kim et al.
patent: 5140033 (1992-08-01), Schriewer et al.
patent: 5202337 (1993-04-01), Petersen et al.
patent: 5498615 (1996-03-01), Kim
D. Bouzard et al., "Fluoronaphtyridines as Antibacterial Agents. 4. Synthesis and Structure-Activity Relationships of 5-Substituted-6-fluoro-7-(cycloaklylamino)-1,4-dihydro-4-oxo-1,8-naphthyri dine-3-carboxylic Acids", J. Med. Chem., vol. 35, No. 3, pp. 518-525 (1992).
Daniel T. W. Chu, "A Regiospecific Synthesis of 1-Methylamino-6-fluoro-7-(4-methylpiperazin-1-yl)-1,4-dihydro-4-oxoquinoli ne-3-carboxylic Acid", J. Heterocyclic Chem., vol. 2, pp. 1033-1034 (Jul.-Aug. 1985).
Daniel T. W. Chu et al., "Synthesis and Structure-Activity Relationships of New Arylfluoronaphthyridine Antibacterial Agents", J. Med. Chem., vol. 29, No. 11, pp. 2363-2369 (1986).
John M. Domagala et al., "37-Substituted 5-Amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acids: Synthesis and Biological Activity of a New Class of Quinolone Antibacterials", J. Med. Chem., vol. 31, No. 3, pp. 503-506 (1988). benzoaine Derivatives Including and Antibacterial Agent, Ofloxacin", Chem. Pharm. Bull., vol. 34, No. 10, pp. 4098-4102 (1986).
H. Saito et al., "AM-1091", Drugs of the Future, vol. 14, No. 10, pp. 931-935 (1989).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Quinolone derivatives and processes for the preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinolone derivatives and processes for the preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolone derivatives and processes for the preparation thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-79513

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.